Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/33028
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDELESIE, Michiel-
dc.contributor.authorKNAEPEN, Lieselotte-
dc.contributor.authorDENDALE, Paul-
dc.contributor.authorVIJGEN, Johan-
dc.contributor.authorEctor, Joris-
dc.contributor.authorVERBEECK, Johan-
dc.contributor.authorBRUYNDONCKX, Robin-
dc.contributor.authorDESTEGHE, Lien-
dc.contributor.authorHEIDBUCHEL, Hein-
dc.date.accessioned2021-01-04T10:57:13Z-
dc.date.available2021-01-04T10:57:13Z-
dc.date.issued2021-
dc.date.submitted2021-01-04T10:44:46Z-
dc.identifier.citationEuropean Journal of Clinical Investigation, 51 (1) (Art N° e13442)-
dc.identifier.issn0014-2972-
dc.identifier.urihttp://hdl.handle.net/1942/33028-
dc.description.sponsorshipThe EduCare-AF study is a project supported by the Fund for Scientific Research, Flanders (T002917N). Use of the elec-tronic Medication Event Monitoring System (MEMS) and MedAmigo web platform was partly supported by AARDEX Group, Liège, Belgium. Statistical support is provided by Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Data Science Institute, Hasselt University, Hasselt, Belgium.The authors would like to thank the advisory committee for their input and insights for optimizing the EduCare-AF trial, namely Philippe Beutels, Health economist and direc-tor of the Centre for health economics research & modelling infectious diseases (University of Antwerp); Dominique Vandijck, Professor in Health Economics (Hasselt University and Ghent University); Dana Berti, Arrhythmic Nurse spe-cialist (Jessa Hospital Hasselt); Bert Aertgeerts, General practitioner and Director of the Academic Centre for General TABLE 1 Tertiary study endpointsTertiary outcome parametersParameterQuestionnaire or toolTime pointScoreEvolution of patients' knowledge about AF and its treatmentJessa Atrial fibrillation Knowledge Questionnaire (JAKQ)Intervention groups: at baseline, 1-, 3-, 6-, 12-,18 mo (s) and at 24-, 30- and 36 mo or at the end of the study (if applicable).Standard care group: at 18 mo and at the end of the study (if applicable).0%-100%Evolution of patients' general quality of lifeEuroQol-5 dimensions-3 Level Questionnaire (EQ-5D-3L)Intervention groups: at baseline, 3-, 12- and 18 mo and at the end of the study (if applicable).Standard care group: at baseline and 18 mo and at the end of the study (if applicable).−0.5-1;Visual analogue scale: 0-100Evolution of patients'AF-related quality of lifeAtrial Fibrillation Effect on QualiTy-of-life questionnaire (AFEQT)Intervention- and standard care groups: at baseline and 18 mo.0-100Evolution of patients' AF-related symptom burdenLeuven Arrhythmia Questionnaire (LARQ)Intervention groups: at baseline, 3-,12- and 18 mo and at the end of the study (if applicable).Standard care group: at baseline, 18 mo and at the end of the study (if applicable).0-100Evolution of patients' self-care questionnaireSelf-Care Questionnaire (SCQ)Intervention groups: at baseline, 3-,12- and 18 mo and at the end of the study (if applicable). Standard care group: at baseline, 18 mo and at the end of the study (if applicable)./Patients' satisfaction of each educational effortPatient reported outcome measures (PROM)Intervention groups: at 12 mo Standard care group: at 18 mo./Patients' adherence to their oral anticoagulationMEMS capIntervention groups: using the smart Cap; between 0-3 mo and 12-15 mo.Sample of standard care group: using the track cap; between 0-3 mo and 12-15 mo.Taking adherence, regimen adherence and unprotected daysaaTaking adherence = proportion of prescribed doses taken; regimen adherence = proportion of days with the correct number of doses taken; unprotected days = once daily regimen: miss 1 dose or take ≥ 1 excess dose on a single day; twice daily regimen: miss 3 consecutive doses or take ≥ 1 excess dose on a single day. Practice, University of Leuven; Roy Remmen, General prac-titioner and Professor in Primary and Interdisciplinary Care, (University of Antwerp), Jan Jansen, Representative of the so-ciety of heart patients Limburg; Arne Janssen, Coordinator of the clinical trial unit cardiology, Jessa Hospital Hasselt; Marc Fabry, General practitioner, Herkenrode Huisartsenkring, Diepenbeek; Eline Thys, General practitioner, Herkenrode Huisartsenkring, Hasselt; Dirk Scheveneels, General prac-titioner, Huisartsenvereniging Wilrijk; Kathleen Van Aken, General practitioner, Huisartsenpraktijk ‘De Hoeksteen' and president of the general practitioners of the region Mortsel (Antwerp)-
dc.language.isoen-
dc.publisher-
dc.rights2020 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd-
dc.subject.otheratrial fibrillation-
dc.subject.othereducation-
dc.subject.otherintegrated care-
dc.titleEffect of targeted education for atrial fibrillation patients: Design of the EduCare-AF Study-
dc.typeJournal Contribution-
dc.identifier.issue1-
dc.identifier.volume51-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedLetter-
local.bibliographicCitation.artnre13442-
dc.identifier.doi10.1111/eci.13442-
dc.identifier.pmid33128229-
dc.identifier.isiWOS:000589669700001-
dc.identifier.eissn1365-2362-
local.provider.typePdf-
local.uhasselt.internationalno-
item.contributorDELESIE, Michiel-
item.contributorKNAEPEN, Lieselotte-
item.contributorDENDALE, Paul-
item.contributorVIJGEN, Johan-
item.contributorEctor, Joris-
item.contributorVERBEECK, Johan-
item.contributorBRUYNDONCKX, Robin-
item.contributorDESTEGHE, Lien-
item.contributorHEIDBUCHEL, Hein-
item.fullcitationDELESIE, Michiel; KNAEPEN, Lieselotte; DENDALE, Paul; VIJGEN, Johan; Ector, Joris; VERBEECK, Johan; BRUYNDONCKX, Robin; DESTEGHE, Lien & HEIDBUCHEL, Hein (2021) Effect of targeted education for atrial fibrillation patients: Design of the EduCare-AF Study. In: European Journal of Clinical Investigation, 51 (1) (Art N° e13442).-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
item.validationecoom 2021-
crisitem.journal.issn0014-2972-
crisitem.journal.eissn1365-2362-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Delesie_2020_EurJClinInvest_EduCare_AF.pdfPeer-reviewed author version7.58 MBAdobe PDFView/Open
eci.13442.pdf
  Restricted Access		Published version374.91 kBAdobe PDFView/Open    Request a copy
Show simple item record

WEB OF SCIENCETM
Citations

7
checked on Apr 30, 2024

Page view(s)

52
checked on Jun 15, 2022

Download(s)

34
checked on Jun 15, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.